[go: up one dir, main page]

AR024158A1 - Compuestos antibacterianos - Google Patents

Compuestos antibacterianos

Info

Publication number
AR024158A1
AR024158A1 ARP000102666A ARP000102666A AR024158A1 AR 024158 A1 AR024158 A1 AR 024158A1 AR P000102666 A ARP000102666 A AR P000102666A AR P000102666 A ARP000102666 A AR P000102666A AR 024158 A1 AR024158 A1 AR 024158A1
Authority
AR
Argentina
Prior art keywords
alkyl
antibacterial compounds
compounds
cf3s
sulfoxyl
Prior art date
Application number
ARP000102666A
Other languages
English (en)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AR024158A1 publication Critical patent/AR024158A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se describen compuestos de formula (1) que son inhibidores de Fab I y son utiles en el tratamiento de infecciones bacterianas en la cual R1 es Ar o Het; R2es H, alquilo C1-6 o Ar-alquilo C0-6; X es H, alquilo C1-4, OR. SR, alquilo C1-4-sulfonilo, alquilo C1-4-sulfoxilo, CN, N(R)2, NO2, CF3, CO2R, CON(R)2,COR, NRC(O)R, F, Cl, Br, I o CF3S(O)r; R es H,alquilo C1-6 o Ar-alquilo C0-6; y r es 0, 1 o 2; o una sal farmacéuticamente aceptable de los mismos.
ARP000102666A 1999-06-01 2000-05-30 Compuestos antibacterianos AR024158A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13700499P 1999-06-01 1999-06-01

Publications (1)

Publication Number Publication Date
AR024158A1 true AR024158A1 (es) 2002-09-04

Family

ID=22475391

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000102666A AR024158A1 (es) 1999-06-01 2000-05-30 Compuestos antibacterianos

Country Status (23)

Country Link
US (2) US6573272B1 (es)
EP (1) EP1180030B1 (es)
JP (1) JP4733836B2 (es)
KR (1) KR20020005767A (es)
CN (1) CN1365280A (es)
AR (1) AR024158A1 (es)
AT (1) ATE283049T1 (es)
AU (1) AU773550B2 (es)
BR (1) BR0011121A (es)
CA (1) CA2375630A1 (es)
CO (1) CO5370679A1 (es)
CZ (1) CZ20014290A3 (es)
DE (1) DE60016198T2 (es)
HK (1) HK1045644A1 (es)
HU (1) HUP0201206A3 (es)
IL (1) IL146514A0 (es)
MX (1) MXPA01012326A (es)
NO (1) NO20015722L (es)
NZ (1) NZ515611A (es)
PL (1) PL351959A1 (es)
TR (1) TR200103485T2 (es)
WO (1) WO2000072846A1 (es)
ZA (1) ZA200109733B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5180550A1 (es) 1999-04-19 2002-07-30 Smithkline Beecham Corp Inhibidores de fab i
AR024158A1 (es) 1999-06-01 2002-09-04 Smithkline Beecham Corp Compuestos antibacterianos
US6730684B1 (en) * 1999-10-08 2004-05-04 Affinium Pharmaceuticals, Inc. Fab I inhibitors
AU7866300A (en) * 1999-10-08 2001-04-23 Smithkline Beecham Corporation Fab i inhibitors
HK1049656A1 (zh) 1999-10-08 2003-05-23 Smithkline Beecham Corporation Fab i抑制剂
US6762201B1 (en) 1999-10-08 2004-07-13 Affinium Pharmaceuticals, Inc. Fab I inhibitors
EP1347759B1 (en) * 2000-12-08 2005-06-29 Smithkline Beecham Corporation Antibacterial compounds
EP1363654B1 (en) * 2000-12-21 2008-07-30 Rima W. Mcleod Fab i and inhibition of apicomplexan parasites
EP1360185B1 (en) * 2001-02-12 2005-08-24 Lilly Icos LLC Carboline derivatives
DE60230934D1 (de) * 2001-04-06 2009-03-05 Affinium Pharm Inc Fab-i-inhibitoren
CA2508792C (en) * 2002-12-06 2013-02-05 Affinium Pharmaceuticals, Inc. Heterocyclic compounds, methods of making them and their use in therapy
JP4880448B2 (ja) * 2003-03-17 2012-02-22 アフィナム ファーマシューティカルズ,インコーポレーテッド 複数の抗生物質を含む組成物、及びそれを用いる方法
EP1628977B1 (en) * 2003-04-29 2008-11-12 Oscient Pharmaceuticals ANTIBIOTIC TETRAHYDRO-b-CARBOLINE DERIVATIVES
DK1828167T3 (da) * 2004-06-04 2014-10-20 Debiopharm Int Sa Acrylamidderivater som antibiotiske midler
US20090156578A1 (en) * 2005-12-05 2009-06-18 PAULS Henry 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
JP5468899B2 (ja) 2006-07-20 2014-04-09 アフィニウム ファーマシューティカルズ, インク. Fabiインヒビターとしてのアクリルアミド誘導体
US7854963B2 (en) * 2006-10-13 2010-12-21 Solopower, Inc. Method and apparatus for controlling composition profile of copper indium gallium chalcogenide layers
EP2125802A4 (en) 2007-02-16 2014-08-20 Debiopharm Int Sa SALTS, PRODRUGS AND POLYMORPHES OF FAB I INHIBITORS
EP2225250A2 (en) * 2007-11-30 2010-09-08 Biota Scientific Management Pty Ltd Bicyclic ppat inhibitors as antibacterial agents
KR101135179B1 (ko) * 2009-02-20 2012-04-16 한국생명공학연구원 FabI 저해 물질 비나산손을 포함하는 항균용 조성물
ES2587856T3 (es) 2011-03-18 2016-10-27 Ono Pharmaceutical Co., Ltd. Derivado de tetrahidrocarbolina
SMT201900411T1 (it) 2012-06-19 2019-09-09 Debiopharm Int Sa Derivati di profaramci di (e)-n-metil-n-((3-metilbenzofuran-2-il)metil -3-(7-osso-5,6,7,8-tetraidro-1,8-naftiridin-3-il)acrilammide
HUE052140T2 (hu) 2016-02-26 2021-04-28 Debiopharm Int Sa Diabéteszes lábfertõzések kezelésére szolgáló gyógyszer
JP2021534246A (ja) 2018-08-16 2021-12-09 レクレオ ファーマシューティカルス アイエヌシー 1,3,4,9−テトラヒドロ−2h−ピリド[3,4−b]インドール誘導体化合物及びその使用
JP7383715B2 (ja) 2019-02-14 2023-11-20 デバイオファーム インターナショナル エス.エー. アファビシン製剤、その作製方法及びその使用
EA202290048A1 (ru) 2019-06-14 2022-03-10 Дебиофарм Интернэшнл C.A. Лекарственное средство и его применение для лечения бактериальных инфекций, связанных с биопленкой

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3828068A (en) 1971-05-10 1974-08-06 Tenneco Chem ((substituted indazolyl)-n1-methyl)carbamates
US4154943A (en) 1977-12-29 1979-05-15 University Of Vermont Preparation of vincadifformine
US4267330A (en) * 1978-08-24 1981-05-12 Omnium Chimique Societe Anonyme Process for the synthesis of vincadifformine and related derivatives
FR2619111B1 (fr) * 1987-08-07 1991-01-11 Synthelabo Derives de (piperidinyl-4)methyl-2 tetrahydro-1,2,3,4 9h-pyrido (3,4-b) indole, leur preparation et leur application en therapeutique
FR2692575B1 (fr) 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
US5416193A (en) * 1993-04-30 1995-05-16 Pfizer Inc. Coupling reagent and method
MA23420A1 (fr) 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.
US5614551A (en) 1994-01-24 1997-03-25 The Johns Hopkins University Inhibitors of fatty acid synthesis as antimicrobial agents
HUT76344A (en) 1994-06-29 1997-08-28 Smithkline Beecham Corp Vitronectin receptor antagonists
DE19624659A1 (de) 1996-06-20 1998-01-08 Klinge Co Chem Pharm Fab Neue Pyridylalken- und Pyridylalkinsäureamide
US6451816B1 (en) 1997-06-20 2002-09-17 Klinge Pharma Gmbh Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression
JPH10310582A (ja) * 1997-03-13 1998-11-24 Sankyo Co Ltd ピペリジン環縮合カルバペネム化合物
AU6870098A (en) 1997-03-31 1998-10-22 Du Pont Merck Pharmaceutical Company, The Indazoles of cyclic ureas useful as hiv protease inhibitors
US6207679B1 (en) 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
US5932743A (en) 1997-08-21 1999-08-03 American Home Products Corporation Methods for the solid phase synthesis of substituted indole compounds
SI1042287T1 (en) * 1997-12-24 2005-10-31 Aventis Pharma Deutschland Gmbh Indole derivatives as inhibitors of factor xa
OA11599A (en) * 1998-08-20 2004-08-23 Agouron Pharma Non-peptide GnRH agents, methods and intermediatesfor their preparation.
GT199900167A (es) * 1998-10-01 2001-03-21 Nuevos bis-benzimidazoles.
CO5180550A1 (es) 1999-04-19 2002-07-30 Smithkline Beecham Corp Inhibidores de fab i
AR024077A1 (es) 1999-05-25 2002-09-04 Smithkline Beecham Corp Compuestos antibacterianos
AR024158A1 (es) 1999-06-01 2002-09-04 Smithkline Beecham Corp Compuestos antibacterianos
CO5180605A1 (es) 1999-06-23 2002-07-30 Smithkline Beecham Corp Compuestos de indol
US6346391B1 (en) 1999-07-22 2002-02-12 Trustees Of Tufts College Methods of reducing microbial resistance to drugs
HK1049656A1 (zh) 1999-10-08 2003-05-23 Smithkline Beecham Corporation Fab i抑制剂
AU7866300A (en) 1999-10-08 2001-04-23 Smithkline Beecham Corporation Fab i inhibitors
EP1225895B1 (en) 1999-10-08 2005-05-04 Affinium Pharmaceuticals, Inc. Fab i inhibitors
CA2323008C (en) 1999-10-11 2005-07-12 Pfizer Inc. Pharmaceutically active compounds
US6656703B1 (en) 1999-12-29 2003-12-02 Millennium Pharamaceuticals, Inc. High throughput screen for inhibitors of fatty acid biosynthesis in bacteria
US6372752B1 (en) 2000-02-07 2002-04-16 Genzyme Corporation Inha inhibitors and methods of use thereof
HUP0400651A2 (hu) 2000-11-07 2004-06-28 Bristol-Myers Squibb Company Szerin proteáz inhibitorokként alkalmazható savszármazékok és ezeket tartalmazó gyógyszerkészítmények
AU2002232558A1 (en) 2000-12-12 2002-06-24 Corvas International, Inc. Compounds, compositions and methods for treatment of parasitic infections

Also Published As

Publication number Publication date
CA2375630A1 (en) 2000-12-07
HUP0201206A2 (en) 2002-08-28
DE60016198D1 (de) 2004-12-30
EP1180030A1 (en) 2002-02-20
AU5177400A (en) 2000-12-18
US6964970B2 (en) 2005-11-15
HK1045644A1 (zh) 2002-12-06
HUP0201206A3 (en) 2003-07-28
TR200103485T2 (tr) 2002-04-22
KR20020005767A (ko) 2002-01-17
US20030232850A1 (en) 2003-12-18
WO2000072846A1 (en) 2000-12-07
NZ515611A (en) 2004-05-28
CZ20014290A3 (cs) 2002-05-15
IL146514A0 (en) 2002-07-25
ZA200109733B (en) 2002-09-11
AU773550B2 (en) 2004-05-27
MXPA01012326A (es) 2002-07-30
PL351959A1 (en) 2003-07-14
EP1180030B1 (en) 2004-11-24
EP1180030A4 (en) 2002-09-25
ATE283049T1 (de) 2004-12-15
JP4733836B2 (ja) 2011-07-27
CN1365280A (zh) 2002-08-21
BR0011121A (pt) 2002-02-26
DE60016198T2 (de) 2005-12-01
JP2003500448A (ja) 2003-01-07
US6573272B1 (en) 2003-06-03
NO20015722D0 (no) 2001-11-23
CO5370679A1 (es) 2004-02-27
NO20015722L (no) 2001-11-23

Similar Documents

Publication Publication Date Title
AR024158A1 (es) Compuestos antibacterianos
ATE332130T1 (de) Fab-i-hemmer
AR025976A1 (es) Inhibidores de fab i.
EA199900591A1 (ru) АЗОТСОДЕРЖАЩИЕ ГЕТЕРОАРОМАТИЧЕСКИЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ ФАКТОРА Ха
AR024077A1 (es) Compuestos antibacterianos
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
ATE297203T1 (de) Antithrombotische mitteln
ATE403429T1 (de) Spiropyrazol-verbindungen
MX9708627A (es) Oxazolidinonas de diazinilo y carbazinilo espirociclicas y biciclicas.
CA2160881A1 (en) 10,11-methanodibenzosuberane derivatives used as chemosensitizing agents
NO20034291D0 (no) 2-aminopropanolderivater
EA200100412A1 (ru) Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
EA200400361A1 (ru) Производные алкинарилнафтиридин-4(1h)-онов в качестве ингибитора фосфодиэстеразы типа iv
TR199902593T2 (xx) �kame edilmi� fenil t�revleri, bunlar�n haz�rlanmas� ve kullan�m�.
SE0004245D0 (sv) Novel compounds and their use
DE60221508D1 (de) Aminosäurederivate als hiv-protease-inhibitoren
FI924725A0 (fi) Antiinflammatoriska hydroxiaminsyror och n-hydroxiureor
ATE298570T1 (de) Antibakterielle verbindungen
PT1157998E (pt) Compostos heterociclicos seus intermediarios e inibidores da elastase
NO944371D0 (no) Kjemisk forbindelse med blodplateaggregeringsinhiberende virkning
PT1044186E (pt) Composto 2-benzilamino-2-fenil-acetamida substituidos
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
UA27900C2 (uk) Фунгіцидна композиція та спосіб боротьби з грибковими інфекціями рослин
NO20062629L (no) Oksazolderivater av tetrackliner
NO331012B1 (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler

Legal Events

Date Code Title Description
FA Abandonment or withdrawal